News
-
Dispensary Corner
Monday | Jul 23 2018
23 Jul 18'LOVE Your Loo' is to be the catchcry of the Metropolitan Sewer District of Greater Cincinnati in an effort to stem the tide of weird objects people flush down their toilets.
-
Events Calendar 20 July 18
Friday | Jul 20 201827 – 29 Jul: PSA18; The Hyatt Regency Sydney; register now: go to www.psa18.com, 9 –.
-
Sigma awards top suppliers
Friday | Jul 20 2018NOVARTIS has been named Sigma's 2018 Supplier of the Year during a gala awards dinner in Melbourne last night.
-
Arrow-Apotex deadline today
Friday | Jul 20 2018SUBMISSIONS to the Australian Competition and Consumer Commission's informal enquiry into the proposed merger between Arrow Pharmaceuticals and Apotex (PD 10 Jul) must be lodged by 5pm AEST today.
-
Non-script antibiotics
Friday | Jul 20 2018WITH increased use of antibiotics worldwide linked to growing antibiotic resistance, a world-first study co-authored by a QUT researcher has highlighted the growing impact of non-prescription supply of antibiotics in community pharmacies, and the urgent need for better enforcement of laws.
-
Botanix antimicrobial
Friday | Jul 20 2018LISTED medical dermatology company Botanix Pharmaceuticals has announced it has signed a research agreement with the University of Queensland's (UQ) Institute for Molecular Bioscience.
-
Cyber security threats
Friday | Jul 20 2018THE Pharmacy Guild of Australia has announced that the ceo of cyber security consultancy firm Hivint, Nick Ellsmore, will present a session at Pharmacy Connect to help pharmacy owners protect their pharmacy from malicious and unintentional data breaches of highly sensitive patient and financial information.
-
Ketoacidosis risk
Friday | Jul 20 2018THE Therapeutic Goods Administration (TGA) has issued a safety advisory around the administration of sodium glucose co-transporter 2 (SGLT2) inhibitors (dapagliflozin and empagliflozin) and increased risk of diabetic ketoacidosis especially perioperatively - medicine information documents are being updated - see tga.gov.au.
-
NSW ERRCD review
Friday | Jul 20 2018NSW Health has confirmed a three-month review of the state's Electronic Recording and Reporting of Controlled Drugs (ERRCD) capabilities, with the $351,796.50 contract to be undertaken by consulting firm Deloitte.